This analysis explores trends in first-time GLP-1 prescriptions alongside newly diagnosed comorbidities, offering insights into prescribing behaviors, patient profiles, and the evolving role of GLP-1 therapies in managing complex conditions like diabetes, obesity, and cardiovascular risk.